Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

50%

2 trials in Phase 3/4

Results Transparency

0 of 1 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A

1(25.0%)

Phase 2

1(25.0%)

Phase 3

1(25.0%)

Phase 4

1(25.0%)

4Total

N/A(1)

Phase 2(1)

Phase 3(1)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials

NCT07146386Phase 3Not Yet Recruiting

A Phase III Clinical Study of H077 Sustained-Release Tablets Compared With Silodosin Capsules in the Treatment of Benign Prostatic Hyperplasia

Role: lead

NCT07134907Phase 4Completed

The Efficacy and Safety of Qianweitai (Silodosin Capsule) Versus Tamsulosin in the Treatment of BPH

Role: lead

NCT06958861Phase 2Not Yet Recruiting

A Clinical Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Inhaled H057 in the Treatment of Acute Exacerbations of Bronchiectasis

Role: lead

NCT06387823Not ApplicableRecruiting

Efficacy and Safety of Sivelestat Sodium and Dexamethasone in the Treatment of ARDS

Role: collaborator

All 4 trials loaded